181 related articles for article (PubMed ID: 18568)
1. The pharmacology of benoxaprofen (2-[4-chlorophenyl]-alpha-methyl-5-benzoxazole acetic acid), LRCL 3794, a new compound with antiinflammatory activity apparently unrelated to inhibition of prostaglandin synthesis.
Cashin CH; Dawson W; Kitchen EA
J Pharm Pharmacol; 1977 Jun; 29(6):330-6. PubMed ID: 18568
[TBL] [Abstract][Full Text] [Related]
2. The comparative pharmacology of benoxaprofen.
Dawson W
J Rheumatol Suppl; 1980; 6():5-11. PubMed ID: 6771399
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological activity of FPP028 (2-phenylpyrazolo-4-ethyl-4,7-dihydro [1,5a]pyrimidin-7-one) a new non-steroid anti-inflammatory agent.
Pirisino R; Bianchini F; Banchelli G; Ignesti G; Raimondi L; Pecori-Vettori L; Rafanelli D
Pharmacol Res Commun; 1986 Mar; 18(3):241-56. PubMed ID: 3487802
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory, analgesic and antipyretic effects of friedelin isolated from Azima tetracantha Lam. in mouse and rat models.
Antonisamy P; Duraipandiyan V; Ignacimuthu S
J Pharm Pharmacol; 2011 Aug; 63(8):1070-7. PubMed ID: 21718291
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological properties of a new anti-inflammatory compound, alpha-(3,5-di-tert-butyl-4-hydroxybenzylidene)-gamma-butyrolacto ne (KME-4), and its inhibitory effects on prostaglandin synthetase and 5-lipoxygenase.
Hidaka T; Hosoe K; Ariki Y; Takeo K; Yamashita T; Katsumi I; Kondo H; Yamashita K; Watanabe K
Jpn J Pharmacol; 1984 Sep; 36(1):77-85. PubMed ID: 6438380
[TBL] [Abstract][Full Text] [Related]
6. The antiinflammatory profile of (5H-dibenzo[a,d]-cyclohepten-5-ylidene)acetic acid (WY-41,770), an agent possessing weak prostaglandin synthetase inhibitory activity that is devoid of gastric side effects.
Carlson RP; Datko LJ; Chang J; Nielsen ST; Lewis AJ
Agents Actions; 1984 Jun; 14(5-6):654-61. PubMed ID: 6433676
[TBL] [Abstract][Full Text] [Related]
7. The anti-allergic activity of Benoxaprofen [2-(4-chlorophenyl)-alpha-methyl-5-benzoxazole acetic acid]--a lipoxygenase inhibitor.
Boot JR; Sweatman WJ; Cox BA; Stone K; Dawson W
Int Arch Allergy Appl Immunol; 1982; 67(4):340-3. PubMed ID: 6175583
[TBL] [Abstract][Full Text] [Related]
8. Relation between plasma concentration and therapeutic efficacy of a new anti-inflammatory compound, benoxaprofen (LRCL 3794) in rats with adjuvant-induced arthritis.
Chatfield DH; Cashin CH; Kitchen EA; Green JN
J Pharm Pharmacol; 1977 Jun; 29(6):371-2. PubMed ID: 18577
[No Abstract] [Full Text] [Related]
9. Nabumetone (BRL 14777, 4-[6-methoxy-2-naphthyl]-butan-2-one): a new anti-inflammatory agent.
Boyle EA; Freeman PC; Mangan FR; Thomson MJ
J Pharm Pharmacol; 1982 Sep; 34(9):562-9. PubMed ID: 6127380
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological studies of a new non-steroidal antiinflammatory drug: 2-(5-ethylpyridin-2-yl)benzimidazole (KB-1043).
Ito K; Kagaya H; Fukuda T; Yoshino K; Nose T
Arzneimittelforschung; 1982; 32(1):49-55. PubMed ID: 6977364
[TBL] [Abstract][Full Text] [Related]
11. Antiinflammatory actions of methyl- and phenyl-3-methoxy-4-hydroxy styryl ketones.
Singh GB; Leach GD; Atal CK
Arzneimittelforschung; 1987 Apr; 37(4):435-40. PubMed ID: 3496890
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological activity and toxicity of apyramide: comparison with non-steroidal anti-inflammatory agents.
Sauvaire D; Michel A; Serrano JJ; Richard M
Drugs Exp Clin Res; 1987; 13(5):247-52. PubMed ID: 3500027
[TBL] [Abstract][Full Text] [Related]
13. The antiinflammatory activity of the immunomodulator Wy-18,251 (3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid).
Gilman SC; Carlson RP; Chang J; Lewis AJ
Agents Actions; 1985 Oct; 17(1):53-9. PubMed ID: 3936345
[TBL] [Abstract][Full Text] [Related]
14. The pharmacological properties of fenbufen. A review.
Sloboda AE; Tolman EL; Osterberg AC; Panagides J
Arzneimittelforschung; 1980; 30(4A):716-21. PubMed ID: 7002162
[TBL] [Abstract][Full Text] [Related]
15. The anti-inflammatory and analgesic profile of 6,11-dihydrodibenzo-[b.e.]-thiepin-11-one-3-acetic acid (tiopinac).
Rooks WH; Tomolonis AJ; Maloney PJ; Roszkowski A; Wallach MB
Agents Actions; 1980 Jun; 10(3):266-73. PubMed ID: 6967686
[TBL] [Abstract][Full Text] [Related]
16. A profile of the gastric ulcerogenic activity of benoxaprofen compared with other nonsteroidal anti-inflammatory drugs in rats, stressed or given alcohol, and in pigs.
Rainsford KD
Eur J Rheumatol Inflamm; 1982; 5(2):148-64. PubMed ID: 7084278
[TBL] [Abstract][Full Text] [Related]
17. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.
Nakamura H; Yokoyama Y; Motoyoshi S; Ishii K; Imazu C; Seto Y; Kadokawa T; Shimizu M
Arzneimittelforschung; 1983; 33(11):1555-69. PubMed ID: 6607053
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of prostaglandin synthetase and carrageenan-induced edema by tricyclic analogs of flufenamic acid.
Horodniak JW; Matz ED; Walz DT; Sutton BM; Berkoff CE; Zarembo JE; Bender AD
Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):533-42. PubMed ID: 809819
[TBL] [Abstract][Full Text] [Related]
19. Experimental antiinflammatory and analgesic studies with 3-trifluoromethyl-s-triazolo (3,4-a)-isoquinoline.
Young PR; Dodge PW; Carter GW; Kimura ET
Arch Int Pharmacodyn Ther; 1974 Dec; 212(2):205-13. PubMed ID: 4447404
[No Abstract] [Full Text] [Related]
20. Some aspects of the pharmacology of butibufen, a non-steroidal anti-inflammatory agent.
Aparicio L
Arch Int Pharmacodyn Ther; 1977 May; 227(1):130-41. PubMed ID: 901061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
